Business Daily.
.
A+ R A-

imageLONDON, Oct. 18, 2013 /PRNewswire/ -- AstraZeneca announced that MedImmune, its global biologics research and development arm, has acquired Spirogen, a privately-held biotech company focused on antibody-drug conjugate technology for use in oncology.  Covington & Burling advised......


Page 903 of 2067

Grow Your Business with Times Media
Business Daily Media